p53 Review Article

You have free access to this content

TP53 mutations in human skin cancers†

  1. Giuseppina Giglia-Mari,
  2. Alain Sarasin*

Article first published online: 24 FEB 2003

DOI: 10.1002/humu.10179

Issue

Human Mutation

Human Mutation

Special Issue: Focus on p53 and Cancer

Volume 21, Issue 3, pages 217–228, March 2003

Additional Information

How to Cite

Giglia-Mari, G. and Sarasin, A. (2003), TP53 mutations in human skin cancers. Hum. Mutat., 21: 217–228. doi: 10.1002/humu.10179

Author Information

  1. Laboratory of Genetic Instability and Cancer, UPR 2169-CNRS, Villejuif, France

*CNRS, Laboratory of Genetic Instability and Cancer, Institut Gustova Roussy, 39, Rue C. Desmoulins, 94805, Villejuif Cedex, France

  1. †

    For the p53 Special Issue

Publication History

  1. Issue published online: 24 FEB 2003
  2. Article first published online: 24 FEB 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (444K)

REFERENCES

  • Barnes DE, Tomkinson AE, Lehmann AR, Webster AD, Lindahl T. 1992. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell 69:495–503.
  • Beroud C, Soussi T. 2003. The UMD-p53 database: new mutations and analysis tools. Hum Mutat 21:176–181.
    Direct Link:
  • Black HS, deGruijl FR, Forbes PD, Cleaver JE, Ananthaswamy HN, deFabo EC, Ullrich SE, Tyrrell RM. 1997. Photocarcinogenesis: an overview. J Photochem Photobiol B 40:29–47.
  • Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, Daya-Grosjean L. 1999. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci USA 96:5117–5122.
  • Bohr VA, Smith CA, Okumoto DS, Hanawalt PC. 1985. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40:359–369.
  • Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NG, Fawcett H, Raams A, Garritsen VH, Stary A, Avril MF, Boudsocq F, Masutani C, Hanaoka F, Fuchs RP, Sarasin A, Lehmann AR. 2002. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99:815–820.
  • Cariello NF, Cui L, Beroud C, Soussi T. 1994. Database and software for the analysis of mutations in the human p53 gene. Cancer Res 54:4454–4460.
  • Cho Y, Gorina S, Jeffrey PD, Pavletich NP. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346–355.
  • Cordonnier AM, Lehmann AR, Fuchs RP. 1999. Impaired translesion synthesis in xeroderma pigmentosum variant extracts. Mol Cell Biol 19:2206–2211.
  • D'Errico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, Corona R, Vorechovsky I, Nardo T, Stefanini M, Dogliotti E. 2000. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 19:463–467.
  • de Laat WL, Appeldoorn E, Sugasawa K, Weterings E, Jaspers NG, Hoeijmakers JH. 1998. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. Genes Dev 12:2598–2609.
  • Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. 1993. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 90:10529–10533.
  • Dumaz N, Stary A, Soussi T, Daya-Grosjean L, Sarasin A. 1994. Can we predict solar ultraviolet radiation as the causal event in human tumors by analysing the mutation spectra of the p53 gene? Mutat Res 307:375–386.
  • Evans E, Moggs JG, Hwang JR, Egly JM, Wood RD. 1997. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. Embo J 16:6559–6573.
  • Frederico LA, Kunkel TA, Shaw BR. 1990. A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 29:2532–2537.
  • Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A. 1998. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res 58:4402–4409.
  • Goldberg LH. 1996. Basal cell carcinoma. Lancet 347:663–667.
  • Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. 1996. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–851.
  • Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366–374.
  • Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC. 1994. Germline p16 mutations in familial melanoma. Nat Genet 8:15–21.
  • Iyer N, Reagan MS, Wu KJ, Canagarajah B, Friedberg EC. 1996. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. Biochemistry 35:2157–2167.
  • Johnson RE, Kondratick CM, Prakash S, Prakash L. 1999. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285:263–265.
  • Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP. 1996. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668–1671.
  • Kraemer KH, Lee MM, Scotto J. 1987. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250.
  • Kraemer KH, Lee MM, Andrews AD, Lambert WC. 1994. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130:1018–1021.
  • Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, Cooper PK. 2000. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell 101:159–171.
  • Li L, Elledge SJ, Peterson CA, Bales ES, Legerski RJ. 1994. Specific association between the human DNA repair proteins XPA and ERCC1. Proc Natl Acad Sci USA 91:5012–5016.
  • Magewu AN, Jones PA. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14:4225–4532.
  • Marks R. 1996. Squamous cell carcinoma. Lancet 347:735–738.
  • Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, Hanaoka F. 1999. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399:700–704.
  • Masutani C, Kusumoto R, Iwai S, Hanaoka F. 2000. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. Embo J 19:3100–3109.
  • Matsumura Y, Sato M, Nishigori C, Zghal M, Yagi T, Imamura S, Takebe H. 1995. High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xeroderma pigmentosum patients. J Invest Dermatol 105:399–401.
  • McGregor WG, Wei D, Maher VM, McCormick JJ. 1999. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light. Mol Cell Biol 19:147–154.
  • Mellon I, Spivak G, Hanawalt PC. 1987. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51:241–249.
  • Mu D, Sancar A. 1997. Model for XPC-independent transcription-coupled repair of pyrimidine dimers in humans. J Biol Chem 272:7570–7573.
  • Mullenders LH, Hazekamp-van Dokkum AM, Kalle WH, Vrieling H, Zdzienicka MZ, van Zeeland AA. 1993. UV-induced photolesions, their repair and mutations. Mutat Res 299:271–276.
  • O'Donovan A, Davies AA, Moggs JG, West SC, Wood RD. 1994. XPG endonuclease makes the 3' incision in human DNA nucleotide excision repair. Nature 371:432–435.
  • Papp T, Jafari M, Schiffmann D. 1996. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions. J Cancer Res Clin Oncol 122:541–548.
  • Park CH, Sancar A. 1994. Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins. Proc Natl Acad Sci USA 91:5017–5021.
  • Park CH, Mu D, Reardon JT, Sancar A. 1995. The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J Biol Chem 270:4896–4902.
  • Queille S, Drougard C, Sarasin A, Daya-Grosjean L. 2001. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes. J Invest Dermatol 117:1162–1170.
  • Rivers JK. 1996. Melanoma. Lancet 347:803–806.
  • Sato M, Nishigori C, Zghal M, Yagi T, Takebe H. 1993. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res 53:2944–2946.
  • Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P, Egly JM. 1993. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260:58–63.
  • Schaeffer L, Moncollin V, Roy R, Staub A, Mezzina M, Sarasin A, Weeda G, Hoeijmakers JH, Egly JM. 1994. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. Embo J 13:2388–2392.
  • Shivji MK, Podust VN, Hubscher U, Wood RD. 1995. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry 34:5011–5017.
  • Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, Moggs JG, Carter KC, Shell BK, Evans E, de Jong MC, Rademakers S, de Rooij J, Jaspers NG, Hoeijmakers JH, Wood RD. 1996. Xeroderma pigmentosum group F caused by a defect in a structure- specific DNA repair endonuclease. Cell 86:811–822.
  • Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N. 2000. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 92:1841–1847.
  • Soussi T, Beroud C. 2003. Significance of p53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides. Hum Mutat 21:192–200.
    Direct Link:
  • Spatz A, Giglia-Mari G, Benhamou S, Sarasin A. 2001. Association between DNA-repair deficiency and high level of P53 mutations in melanoma of xeroderma pigmentosum patients. Cancer Res 61:2480–2486.
  • Stary A, Sarasin A. 2002. The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84:49–60.
  • Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH. 1998. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2:223–232.
  • Sugasawa K, Okamoto T, Shimizu Y, Masutani C, Iwai S, Hanaoka F. 2001. A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev 15:507–521.
  • Tornaletti S, Pfeifer GP. 1994. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436–1438.
  • Tornaletti S, Pfeifer GP. 1995. Complete and tissue-inde-pendent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10:1493–1499.
  • Tu Y, Dammann R, Pfeifer GP. 1998. Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo. J Mol Biol 284:297—311.
  • Volker M, Moné MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W, Hoeijmakers JHJ, van Driel R, van Zeeland AA, Mullenders LHF. 2001. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 8:213–224.
  • Wang CI, Taylor JS. 1991. Site-specific effect of thymine dimer formation on dAn.dTn tract bending and its biological implications. Proc Natl Acad Sci USA 88:9072–9076.
  • Wang YC, Maher VM, Mitchell DL, McCormick JJ. 1993. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts. Mol Cell Biol 13:4276–4283.
  • Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE. 1994. Sunburn and p53 in the onset of skin cancer. Nature 372:773–776.
Get PDF (444K)